Intestinotrophic effects of exogenous IGF-I are not diminished in IGF binding protein-5 knockout mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 6, 2007, Pages

  Murali, Sangita G ^a   Liu, Xiaowen ^a   Nelson, David W ^a   Hull, Angela K ^a   Grahn, Michael ^a   Clayton, Murray K ^a   Pintar, John E ^b   Ney, Denise M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

IGF binding proteins 3 and 5; Jejunum; Total parenteral nutrition

Indexed keywords

DNA; MESSENGER RNA; PARENTERAL SOLUTION; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; COLON; CONTROLLED STUDY; CRYPT CELL; FEMALE; HETEROZYGOTE; JEJUNUM; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE; WILD TYPE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; INTESTINES; MALE; MICE; MICE, KNOCKOUT; PROTEIN BINDING;

EID: 34447525474     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00903.2006     Document Type: Article

References (29)

1. Beattie J, Allan GJ, Lochrie JD, Flint DJ. Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem J 395: 1-19, 2006.
2. Boisclair YR, Rhoads RP, Ueki I, Wang J, Ooi GT. The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. J Endocrinol 170: 63-70, 2001.
3. Bushman TL, Kuemmerle JF. IGFBP-3 and IGFBP-5 production by human intestinal muscle: reciprocal regulation by endogenous TGF-beta1. Am J Physiol Gastrointest Liver Physiol 275: G1282-G1290, 1998.
4. Dahlqvist A. Method for assay of intestinal disaccharidases. Anal Biochem 57: 18-25, 1964.
5. Dahly EM, Guo Z, Ney DM. Alterations in enterocyte proliferation and apoptosis accompany TPN-induced mucosal hypoplasia and IGF-I-induced hyperplasia in rats. J Nutr 132: 2010-2014, 2002.
6. Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE. Molecular interactions of the IGF system. Cytokine Growth Factor Rev 16: 421-439, 2005.
7. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854, 2002.
8. Flint DJ, Tonner E, Allan GJ. Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in the mammary gland. J Mammary Gland Biol Neoplasia 5: 65-73, 2000.
9. Gillingham MB, Dahly EM, Murali SG, Ney DM. IGF-I treatment facilitates transition from parenteral to enteral nutrition in rats with short bowel syndrome. Am J Physiol Regul Integr Comp Physiol 284: R363-R371, 2003.
10. Gillingham MB, Kritsch KR, Murali SG, Lund PK, Ney DM. Resection upregulates the IGF-I system of parenterally fed rats with jejunocolic anastomosis. Am J Physiol Gastrointest Liver Physiol 281: G1158-G1168, 2001.
11. Govoni KE, Amaar YG, Kramer A, Winter E, Baylink DJ, Mohan S. Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts. Growth Horm IGF Res 16: 49-56, 2006.
12. Hise MK, Mantzouris NM, Lahn JS, Sheikh MS, Shao ZM, Fontana JA. IGF binding protein 5 and IGF-I receptor regulation in hypophysectomized rat kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 266: F147-F154, 1994.
13. Institute for Laboratory Animal Research. Nutrient Requirements of the Mouse. In: Nutrient Requirements of Laboratory Animals, edited by Benevenga NJ. Washington DC: National Academy Press, 1995, p. 80-102.
14. Jehle PM, Fussgaenger RD, Blum WF, Angelus NK, Hoeflich A, Wolf E, Jungwirth RJ. Differential autocrine regulation of intestine epithelial cell proliferation and differentiation by insulin-like growth factor (IGF) system components. Horm Metab Res 31: 97-102, 1999.
15. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 13: 113-170, 2003.
16. Kang W, Gomez FE, Lan J, Sano Y, Ueno C, Kudsk KA. Parenteral nutrition impairs gut-associated lymphoid tissue and mucosal immunity by reducing lymphotoxin Beta receptor expression. Ann Surg 244: 392-399, 2006.
17. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102: 344-352, 1980.
18. Lund PK. IGFs and the digestive tract. The insulin-like growth factors system. In: The IGF System, edited by Roberts CT. Totowa, NJ: Humana, 1999, p. 517-544.
19. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270: 20424-20431, 1995.
20. Murali SG, Nelson DW, Draxler AK, Liu X, Ney DM. Insulin-like growth factor-I (IGF-I) attenuates jejunal atrophy in association with increased expression of IGF-I binding protein-5 in parenterally fed mice. J Nutr 135: 2553-2559, 2005.
21. Ney DM, Yang H, Smith SM, Unterman TG. High-calorie total parenteral nutrition reduces hepatic insulin-like growth factor-I mRNA and alters serum levels of insulin-like growth factor-binding protein-1, -3, -5, and -6 in the rat. Metabolism 44: 152-160, 1995.
22. Ning Y, Schuller AG, Bradshaw S, Rotwein P, Ludwig T, Frystyk J, Pintar JE. Diminished growth and enhanced glucose metabolism in triple knock out mice containing mutations of insulin like-growth factor binding proteins -3, -4, and -5. Mol Endocrinol 20: 2173-2186, 2006.
23. Oguchi S, Walker WA, Sanderson IR. Profile of IGF-binding proteins secreted by intestinal epithelial cells changes with differentiation. Am J Physiol Gastrointest Liver Physiol 267: G843-G850, 1994.
24. Peterson CA, Gillingham MB, Mohapatra NK, Dahly EM, Adamo ML, Carey HV, Lund PK, Ney DM. Enterotrophic effect of insulin-like growth factor-I but not growth hormone and localized expression of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and -5 mRNAs in jejunum of parenterally fed rats. JPEN J Parenter Enteral Nutr 24: 288-295, 2000.
25. Roelfsema V, Lane MH, Clark RG. Insulin-like growth factor binding protein (IGFBP) displacers: relevance to the treatment of renal disease. Pediatr Nephrol 14: 584-588, 2000.
26. Schneider MR, Wolf E, Hoeflich A, Lahm H. IGF-binding protein-5: flexible player in the IGF system and effector on its own. J Endocrinol 172: 423-440, 2002.
27. Silha JV, Murphy LJ. Insights from insulin-like growth factor binding protein transgenic mice. Endocrinology 143: 3711-3714, 2002.
28. Williams KL, Fuller CR, Fagin J, Lund PK. Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions. Am J Physiol Gastrointest Liver Physiol 283: G875-G885, 2002.
29. Zimmermann EM, Li L, Hou YT, Cannon M, Christman GM, Bitar KN. IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle. Am J Physiol Gastrointest Liver Physiol 273: G875-G882, 1997.